Chapter 64: Androgens

Chapter 64: Androgens

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

1. Parents of a pubescent teen are concerned that he has not “developed” at the rate of other boys. The prescriber diagnoses the teen with hypogonadism. The nurse provides patient education about treatment with testosterone injections. Which statement by the parents best indicates understanding of testosterone therapy? “Our son will have to take the injections

a.	until he grows at least 4 inches.”
b.	for 6 to 12 months.”
c.	for 3 to 4 years.”
d.	monthly until the age of 16.”

 

 

ANS:   C

The patient will have to take the injections for at least 3 to 4 years; no further teaching is required.

Testosterone injections are given every 2 to 4 weeks for 3 to 4 years; further teaching is required.

 

DIF:    Cognitive Level: Application             REF:    p. 771

TOP:    Nursing Process: Implementation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

 

2. The nurse is caring for a male teen patient who has been receiving androgen therapy. What diagnostic testing would be needed approximately every 6 months to monitor this patient?

a.	X-ray films of the hands and wrists
b.	Complete blood count (CBC) for anemia
c.	Urinalysis for ketones
d.	Male pattern baldness

 

 

ANS:   A

X-ray films of the hands and wrists would be necessary for this patient, because androgen therapy accelerates epiphyseal closure.

Anemia is not an expected adverse effect of androgen therapy.

Ketones in the urine are not an expected effect of this medication.

Male pattern baldness is not a typical finding associated with androgen therapy in a young teen patient.

 

DIF:    Cognitive Level: Analysis                  REF:    p. 773

TOP:    Nursing Process: Evaluation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

 

3. A nurse working in a private pediatric practice is caring for a patient who has been receiving 17–alpha-alkylated androgen (Fluoxymesterone). Which clinical manifestation would cause the nurse to be concerned, and what intervention would the nurse anticipate?

a.	Gynecomastia; discontinuation of the drug
b.	Yellowish tint to the skin and sclera; discontinuation of the drug
c.	Decrease in high-density lipoprotein (HDL); titration of the medication
d.	Erratic blood glucose levels; adjustment of the dose

 

 

ANS:   B

A yellowish tint to the skin and sclera would most concern the nurse, because 17–alpha-alkylated androgen (Fluoxymesterone) is known to cause hepatotoxicity.

Gynecomastia is expected in males.

A decrease in HDL would require monitoring of those levels but not titration of the medication.

Fluoxymesterone is not associated with erratic blood glucose levels.

 

DIF:    Cognitive Level: Analysis                  REF:    p. 773

TOP:    Nursing Process: Implementation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

 

4. The nurse is discussing testosterone therapy with a male patient. The nurse provides education about the different formulations of the medication. Which statement by the patient best demonstrates misunderstanding of the differences between testosterone patches and testosterone transdermal gel?

a.	“The testosterone in the patch is less likely to be transferred to another person by skin-to-skin contact.”
b.	“The patch is less effective.”
c.	“The patch produces more consistent blood levels of the hormone.”
d.	“The patch causes less local irritation.”

 

 

ANS:   C

Compared with testosterone patches, testosterone transdermal gel produces more consistent blood levels of the hormone.

The testosterone in the patch is less likely to be transferred to another person by skin-to-skin contact.

The patch is less effective than the gel.

The patch causes less local irritation than the gel does.

 

DIF:    Cognitive Level: Application             REF:    p. 771 | p. 774

TOP:    Nursing Process: Evaluation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies